Correlation Between Lipocine and 22822VBA8
Specify exactly 2 symbols:
By analyzing existing cross correlation between Lipocine and CCI 5 11 JAN 28, you can compare the effects of market volatilities on Lipocine and 22822VBA8 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of 22822VBA8. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and 22822VBA8.
Diversification Opportunities for Lipocine and 22822VBA8
Significant diversification
The 3 months correlation between Lipocine and 22822VBA8 is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and CCI 5 11 JAN 28 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 22822VBA8 and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with 22822VBA8. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 22822VBA8 has no effect on the direction of Lipocine i.e., Lipocine and 22822VBA8 go up and down completely randomly.
Pair Corralation between Lipocine and 22822VBA8
Given the investment horizon of 90 days Lipocine is expected to under-perform the 22822VBA8. In addition to that, Lipocine is 17.04 times more volatile than CCI 5 11 JAN 28. It trades about -0.09 of its total potential returns per unit of risk. CCI 5 11 JAN 28 is currently generating about -0.05 per unit of volatility. If you would invest 9,980 in CCI 5 11 JAN 28 on December 26, 2024 and sell it today you would lose (82.00) from holding CCI 5 11 JAN 28 or give up 0.82% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 98.36% |
Values | Daily Returns |
Lipocine vs. CCI 5 11 JAN 28
Performance |
Timeline |
Lipocine |
22822VBA8 |
Lipocine and 22822VBA8 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lipocine and 22822VBA8
The main advantage of trading using opposite Lipocine and 22822VBA8 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, 22822VBA8 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 22822VBA8 will offset losses from the drop in 22822VBA8's long position.Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
22822VBA8 vs. Lindblad Expeditions Holdings | 22822VBA8 vs. United Guardian | 22822VBA8 vs. Old Dominion Freight | 22822VBA8 vs. Ark Restaurants Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |